Getting Melanoma Cells to Stimulate With Frequency
- 10 December 2005
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (35) , 8929-8931
- https://doi.org/10.1200/jco.2005.03.8307
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With AutologousGM-CSF–Transduced Tumor Cells in Metastatic Melanoma PatientsJournal of Clinical Oncology, 2005
- Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed ScheduleJournal of Clinical Oncology, 2004
- On the road to a tumor cell vaccine: 20 years of cellular immunotherapyVaccine, 2004
- Granulocyte-Macrophage Colony Stimulating Factor: An Adjuvant for Cancer VaccinesHematology, 2004
- Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic CellsJournal of Clinical Oncology, 2003
- Vaccination With Irradiated, Autologous Melanoma Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor by Adenoviral-Mediated Gene Transfer Augments Antitumor Immunity in Patients With Metastatic MelanomaJournal of Clinical Oncology, 2003
- Prolonged Survival After Complete Resection of Disseminated Melanoma and Active Immunotherapy With a Therapeutic Cancer VaccineJournal of Clinical Oncology, 2002
- Effects of Interleukin-12 on the Immune Response to a Multipeptide Vaccine for Resected Metastatic MelanomaJournal of Clinical Oncology, 2001
- Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccinesBlood, 1996
- Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.Proceedings of the National Academy of Sciences, 1993